View source for 30341386/Experiment 1

{{Experiment
|Location of subjects=South Korea
|Host species=Homo sapiens
|Body site=Uterus
|Condition=human papilloma virus infection
|Group 0 name=HPV clearance
|Group 1 name=HPV persistent
|Group 1 definition=HPV DNA was detected using the Digene HC2 high-risk DNA test (Qiagen, Gaithersburg, MD, USA) with signal amplification and chemiluminescence for 13 types of HR-HPV scored in RLU/PC. A positive result indicated a concentration of 1 pg/ml or higher than the RLU/cutoff ratio (RLU of the specimen/mean RLU of 2 positive controls).
|Group 0 sample size=15
|Group 1 sample size=16
|Sequencing type=16S
|Sequencing platform=Roche454
|Data transformation=relative abundances
|Statistical test=LEfSe
|Significance threshold=0.05
|MHT correction=No
|LDA Score above=2
|Confounders controlled for=age, contraception, menopause, smoking behavior
|Shannon=unchanged
|Chao1=unchanged
|State=Complete
}}